137 related articles for article (PubMed ID: 9071985)
1. Regulatory peptides and other neuroendocrine markers in medullary carcinoma of the thyroid.
Hanna FW; Ardill JE; Johnston CF; Cunningham RT; Curry WJ; Russell CF; Buchanan KD
J Endocrinol; 1997 Feb; 152(2):275-81. PubMed ID: 9071985
[TBL] [Abstract][Full Text] [Related]
2. Studies on cultured cells of thyroid medullary carcinoma with the use of immunocytochemical techniques.
Seidel J; Zabel M; Kasprzak A
Folia Histochem Cytobiol; 1999; 37(2):63-4. PubMed ID: 10352959
[No Abstract] [Full Text] [Related]
3. Immunocytochemical localization of hormones and functional proteins in cultured cells of thyroid medullary carcinoma.
Seidel J; Zabel M; Kaczmarek A; Grzeszkowiak J; Kasprzak A
Folia Histochem Cytobiol; 1996; 34 Suppl 1():67-8. PubMed ID: 8878649
[No Abstract] [Full Text] [Related]
4. Medullary carcinoma of the thyroid. An immunocytochemical and histochemical study of 25 cases using eight separate markers.
Sikri KL; Varndell IM; Hamid QA; Wilson BS; Kameya T; Ponder BA; Lloyd RV; Bloom SR; Polak JM
Cancer; 1985 Nov; 56(10):2481-91. PubMed ID: 2412687
[TBL] [Abstract][Full Text] [Related]
5. Medullary thyroid carcinomas express chromogranin A and a novel neuroendocrine protein recognized by monoclonal antibody HISL-19.
Deftos LJ; Woloszczuk W; Krisch I; Horvat G; Ulrich W; Neuhold N; Braun O; Reiner A; Srikanta S; Krisch K
Am J Med; 1988 Dec; 85(6):780-4. PubMed ID: 3195602
[TBL] [Abstract][Full Text] [Related]
6. Metastatic neuroendocrine tumors to the thyroid gland mimicking medullary carcinoma: a pathologic and immunohistochemical study of six cases.
Matias-Guiu X; LaGuette J; Puras-Gil AM; Rosai J
Am J Surg Pathol; 1997 Jul; 21(7):754-62. PubMed ID: 9236831
[TBL] [Abstract][Full Text] [Related]
7. [Histopathological and immunohistochemical studies on medullary thyroid carcinoma].
Jiang C; Tan Y; Li E
Zhonghua Bing Li Xue Za Zhi; 1996 Dec; 25(6):332-5. PubMed ID: 9388857
[TBL] [Abstract][Full Text] [Related]
8. Changes in neuroendocrine elements in bronchial mucosa in chronic lung disease in adults.
Pilmane M; Luts A; Sundler F
Thorax; 1995 May; 50(5):551-4. PubMed ID: 7541167
[TBL] [Abstract][Full Text] [Related]
9. Amylin/islet amyloid polypeptide expression in medullary carcinoma of the thyroid: correlation with the expression of the related calcitonin/CGRP genes.
Alevizaki M; Dai K; Grigorakis SI; Legon S; Souvatzoglou A
Clin Endocrinol (Oxf); 1994 Jul; 41(1):21-6. PubMed ID: 8050128
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical comparison of chromogranins A and B and secretogranin II with calcitonin and calcitonin gene-related peptide expression in normal, hyperplastic and neoplastic C-cells of the human thyroid.
Schmid KW; Kirchmair R; Ladurner D; Fischer-Colbrie R; Böcker W
Histopathology; 1992 Sep; 21(3):225-32. PubMed ID: 1356907
[TBL] [Abstract][Full Text] [Related]
11. Oxyphil and squamous variants of medullary thyroid carcinoma.
Dominguez-Malagon H; Delgado-Chavez R; Torres-Najera M; Gould E; Albores-Saavedra J
Cancer; 1989 Mar; 63(6):1183-8. PubMed ID: 2917321
[TBL] [Abstract][Full Text] [Related]
12. Chromogranin A, neuron-specific enolase and synaptophysin as neuroendocrine cell markers in the diagnosis of tumours of the gastro-entero-pancreatic system.
Schürmann G; Betzler M; Buhr HJ
Eur J Surg Oncol; 1990 Aug; 16(4):298-303. PubMed ID: 2116326
[TBL] [Abstract][Full Text] [Related]
13. Chromogranin A immunoreactivity compared with argyrophilia, calcitonin immunoreactivity, and amyloid as tumour markers in the histopathological diagnosis of medullary (C-cell) thyroid carcinoma.
Harach HR; Wilander E; Grimelius L; Bergholm U; Westermark P; Falkmer S
Pathol Res Pract; 1992 Feb; 188(1-2):123-30. PubMed ID: 1594480
[TBL] [Abstract][Full Text] [Related]
14. Biochemical markers in the follow-up of medullary thyroid cancer.
de Groot JW; Kema IP; Breukelman H; van der Veer E; Wiggers T; Plukker JT; Wolffenbuttel BH; Links TP
Thyroid; 2006 Nov; 16(11):1163-70. PubMed ID: 17123344
[TBL] [Abstract][Full Text] [Related]
15. Chromogranin A: an additional tumor marker for postoperative recurrence and metastases of medullary thyroid carcinomas?
Franke WG; Pinkert J; Runge R; Bredow J; Wunderlich G; Koch R
Anticancer Res; 2000; 20(6D):5257-60. PubMed ID: 11326706
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in medullary thyroid carcinomas. Survival in relation to age, sex, stage, histology, immunocytochemistry, and DNA content.
Schröder S; Böcker W; Baisch H; Bürk CG; Arps H; Meiners I; Kastendieck H; Heitz PU; Klöppel G
Cancer; 1988 Feb; 61(4):806-16. PubMed ID: 2448025
[TBL] [Abstract][Full Text] [Related]
17. Pancreas cancer-associated antigen (PCAA) in medullary thyroid carcinoma.
Ueno K; Kobayashi T; Shimano T; Matsuura N; Monden T; Takeda T; Tomita N; Mori T
Med J Osaka Univ; 1994 Sep; 43(1-4):17-21. PubMed ID: 7609706
[TBL] [Abstract][Full Text] [Related]
18. Immunocytochemical characterization of two thyroid medullary carcinoma cell lines in vitro.
Zabel M; Seidel J; Kaczmarek A; Surdyk-Zasada J; Grzeszkowiak J; Górny A
Histochem J; 1995 Nov; 27(11):859-68. PubMed ID: 8787964
[TBL] [Abstract][Full Text] [Related]
19. [Tumor markers in medullary thyroid carcinoma. Biochemical and immunohistochemical study].
López-Guzmán A; Navarro E; Aramendi T
An Med Interna; 1996 Jul; 13(7):358-9. PubMed ID: 8962990
[No Abstract] [Full Text] [Related]
20. Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer - comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen.
Woliński K; Kaznowski J; Klimowicz A; Maciejewski A; Łapińska-Cwojdzińska D; Gurgul E; Car AD; Fichna M; Gut P; Gryczyńska M; Ruchała M
Endokrynol Pol; 2017; 68(4):434-437. PubMed ID: 28585679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
